Agfa flirts with digital mammography
Hologic hopes to enter a strategic alliance with Agfa to help develop its amorphous selenium digital mammography system. The collaboration, which could be finalized in the next several months, would leverage Agfa's strength in image processing
Hologic hopes to enter a strategic alliance with Agfa to help develop its amorphous selenium digital mammography system. The collaboration, which could be finalized in the next several months, would leverage Agfa's strength in image processing optimization and system integration. Hologic announced its intent to enter a similar alliance late last year with Siemens Medical Solutions (SCAN 12/26/01). The finished version of the digital mammography system would include PACS, data acquisition, and hard-copy readout. Hologic would manufacture systems for sale under its own label as well as that of Agfa. Hologic's alliance with Agfa, if consummated, would also provide for reciprocal distribution rights of Hologic's and Agfa's medical image management systems and workstations.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
